Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
A modified growth hormone-releasing hormone (GHRH) analog that stimulates pulsatile GH release with a short duration of action.
0 of 2 vendors lab-verified
Verified purity per dollar — the cheapest that's actually been tested
vial · 5mg· instantpeptides.com· price updated today
$40.00✓ $8.00/mg
single-vial price — packs may be lower
vial · 5mg· peptidetech.is· price updated today
$39.95✓ $7.99/mg
single-vial price — packs may be lower
2 vendors not shown — trust grade below C, or not enough verified COA data yet. We only list sources with a C grade or better.
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
Best price trend
Lowest $/mg for CJC-1295 (no DAC) · last 45 days
$5.00/mg
▼ 23% vs 45d ago
Peptide Tech has the lowest single-vial CJC-1295 (no DAC) price at $7.99/mg among 2 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower.
What is the price range for CJC-1295 (no DAC)?
Research-grade CJC-1295 (no DAC) ranges from $7.99/mg to $8.00/mg across 2 verified sources.
How are CJC-1295 (no DAC) prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
The parent molecule CJC-1295 (DAC form) was identified by Jetté et al. (Endocrinology, 2005; PMID 15817669) at ConjuChem as a tetrasubstituted GHRH(1-29) bioconjugate that covalently binds Cys34 of serum albumin via a maleimidopropionyl-lysine linker, extending half-life to roughly 5.8–8.1 days. In healthy adults, Teichman et al. (JCEM, 2006; PMID 16352683) showed single SubQ doses of the DAC form produced 2- to 10-fold GH elevations for ≥6 days and 1.5- to 3-fold IGF-1 elevations for 9–11 days, and Ionescu & Frohman (JCEM, 2006; PMID 17018654) demonstrated that pulsatile GH secretion was preserved (7.5-fold increase in trough GH, IGF-1 up 45%). ConjuChem halted Phase 2 lipodystrophy development around 2006–2007 after a participant death in an HIV-visceral-adiposity trial (deemed by the trial physician most likely due to pre-existing coronary artery disease rather than CJC-1295, but the program was not resumed; aidsmap news, July 2006). The no-DAC form described here ('Modified GRF 1-29') shares the same position-2/8/15/27 substitutions (which confer DPP-IV resistance; see Soule et al., JCEM 1994, PMID 7962295 for the foundational D-Ala2 half-life work) but omits the albumin-linker lysine, giving a short (~30 min) half-life similar to sermorelin. No form of CJC-1295 is FDA-approved for any indication. Grey-market compounding practice pairs the no-DAC form with ipamorelin; this combination is not clinically validated for anti-aging, body composition, or performance use, and peer-reviewed human trials of the no-DAC variant specifically are lacking — the 100–300 mcg dosing range reflects community practice, not clinical evidence.
This platform provides informational tools only, not medical advice.
Identification, characterization, and long-lasting effects of a new growth hormone-releasing peptide analogue (CJC-1295) in rats
2005
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of growth hormone-releasing hormone, in healthy adults
2006
Pulsatile growth hormone secretion: insights from recent studies of growth hormone-releasing hormone in children and adults
Prices verified as of July 2026. Actual prices may vary. For research use only.
2006
Disclosed Labs